Lixue Song, Wenyong Huang, Lina Chang, Xin Wang, Qian Sun, Xiaolin Wang, Qing He

2026.5.14World Journal of Diabetes

DOI: 10.4239/wjd.120779

Abstract

BACKGROUND Circulating irisin, a myokine, has been inconsistently associated with prediabetes mellitus (PreDM), and its relationship with glucagon is unexplored. Methodological variability, particularly between different enzyme-linked immunosorbent assay (ELISA) kits, is hypothesized to be a primary source of these discrepancies. Therefore, we hypothesized that the reported irisin-PreDM association is critically confounded by assay methodology and inadequate adjustment for key metabolic factors. AIM To investigate circulating irisin in PreDM via a dual-study approach, evaluating methodological variability and metabolic confounders. METHODS A dual-study design was employed: (1) A systematic review and meta-analysis of observational studies; and (2) A single-center, exploratory case-control study of 35 participants (9 PreDM, 26 controls) from a tertiary hospital. Irisin was measured with two commercial ELISA kits (ELK and Elabscience). Key analyses included random-effects meta-analysis, multiple linear regression, Spearman correlation, and Bland-Altman analysis for inter-assay agreement. RESULTS The meta-analysis (8 studies, n = 788) found significantly lower irisin in PreDM (standardized mean difference = -0.524 , 95% confidence interval: -0.897 to -0.152, P = 0.006) with high heterogeneity (I 2 = 86.7%). In the case-control study, unadjusted analysis showed higher irisin in PreDM with the Elabscience kit (median: 7386.3 pg/mL vs 6332.0 pg/mL, P = 0.045) but not the ELK kit. After adjusting for gender, body mass index, and fatty liver, the association was null for both kits. Bland-Altman analysis revealed poor inter-assay agreement (mean bias: 5837.25 pg/mL). Irisin correlated with fatty liver (ρ = 0.350, P = 0.039) and 0.5-hour glucose (ρ = 0.421, P = 0.012), but not with glucagon. CONCLUSION The irisin-PreDM relationship appears to be influenced by assay methodology and metabolic factors. Standardizing irisin measurement and adjusting for key confounders are important considerations for future research.

Citation format

SONG, Lixue, et al. Irisin levels in patients with prediabetes mellitus: A case-control study and meta-analysis. World Journal of Diabetes, 2026.